FI905814A0 - Farmaceutiska produkter. - Google Patents

Farmaceutiska produkter.

Info

Publication number
FI905814A0
FI905814A0 FI905814A FI905814A FI905814A0 FI 905814 A0 FI905814 A0 FI 905814A0 FI 905814 A FI905814 A FI 905814A FI 905814 A FI905814 A FI 905814A FI 905814 A0 FI905814 A0 FI 905814A0
Authority
FI
Finland
Prior art keywords
weight
denotes
pharmaceutical product
polyloxyethylene
pyrid
Prior art date
Application number
FI905814A
Other languages
English (en)
Other versions
FI103713B1 (fi
FI905814A (fi
FI103713B (fi
Inventor
Walter Fries
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of FI905814A0 publication Critical patent/FI905814A0/fi
Publication of FI905814A publication Critical patent/FI905814A/fi
Application granted granted Critical
Publication of FI103713B1 publication Critical patent/FI103713B1/fi
Publication of FI103713B publication Critical patent/FI103713B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI905814A 1989-11-29 1990-11-26 Menetelmä farmaseuttisen koostumuksen valmistamiseksi parenteraalista antoa varten FI103713B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3939492A DE3939492A1 (de) 1989-11-29 1989-11-29 Pharmazeutische zubereitungen
DE3939492 1989-11-29

Publications (4)

Publication Number Publication Date
FI905814A0 true FI905814A0 (fi) 1990-11-26
FI905814A FI905814A (fi) 1991-05-30
FI103713B1 FI103713B1 (fi) 1999-08-31
FI103713B FI103713B (fi) 1999-08-31

Family

ID=6394433

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905814A FI103713B (fi) 1989-11-29 1990-11-26 Menetelmä farmaseuttisen koostumuksen valmistamiseksi parenteraalista antoa varten

Country Status (29)

Country Link
US (1) US5118698A (fi)
EP (1) EP0430149B1 (fi)
JP (1) JPH0660097B2 (fi)
KR (1) KR940000066B1 (fi)
CN (1) CN1035357C (fi)
AT (1) ATE102051T1 (fi)
AU (1) AU626480B2 (fi)
BR (1) BR9006025A (fi)
CA (1) CA2030911C (fi)
CY (1) CY1970A (fi)
CZ (1) CZ282898B6 (fi)
DE (2) DE3939492A1 (fi)
DK (1) DK0430149T3 (fi)
EG (1) EG19557A (fi)
ES (1) ES2062271T3 (fi)
FI (1) FI103713B (fi)
HK (1) HK216896A (fi)
HU (1) HU220867B1 (fi)
IE (1) IE64672B1 (fi)
IL (1) IL96450A (fi)
MX (1) MX23518A (fi)
MY (1) MY104540A (fi)
NO (1) NO180475C (fi)
NZ (1) NZ236255A (fi)
PT (1) PT96003B (fi)
RU (1) RU2038080C1 (fi)
SK (1) SK280599B6 (fi)
YU (1) YU227290A (fi)
ZA (1) ZA909549B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
EP0532546B1 (en) * 1990-05-10 1998-03-18 Bechgaard International Research And Development A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
JP3485540B2 (ja) * 2000-12-28 2004-01-13 新日本製鐵株式会社 低騒音トランス
MXPA03007766A (es) * 2001-02-28 2004-03-16 Akzo Nobel Nv Emulsiones inyectables de agua en aceite.
ATE464880T1 (de) 2002-02-04 2010-05-15 Elan Pharma Int Ltd Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator
US20040258757A1 (en) * 2002-07-16 2004-12-23 Elan Pharma International, Ltd. Liquid dosage compositions of stable nanoparticulate active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GR79307B (fi) * 1982-06-09 1984-10-22 Pfizer
AU4882685A (en) * 1984-10-19 1986-04-24 Schering Corporation 1,3-bis(1h-1,2,4-triazol-1-yl)-2-fluoro-2-(2,4- difluorophenyl) propane

Also Published As

Publication number Publication date
CN1052046A (zh) 1991-06-12
DE69007029D1 (de) 1994-04-07
HUT57039A (en) 1991-11-28
DE3939492A1 (de) 1991-06-06
FI103713B1 (fi) 1999-08-31
AU6706590A (en) 1991-08-08
EP0430149A2 (en) 1991-06-05
PT96003A (pt) 1991-09-13
JPH03176421A (ja) 1991-07-31
HU220867B1 (en) 2002-06-29
CA2030911C (en) 1995-02-07
AU626480B2 (en) 1992-07-30
CZ282898B6 (cs) 1997-11-12
EG19557A (en) 1997-08-31
FI905814A (fi) 1991-05-30
YU227290A (sh) 1993-10-20
IL96450A (en) 1994-10-21
FI103713B (fi) 1999-08-31
ZA909549B (en) 1992-06-24
BR9006025A (pt) 1991-09-24
CZ595390A3 (en) 1997-06-11
NO905106L (no) 1991-05-30
NO180475C (no) 1997-04-30
ES2062271T3 (es) 1994-12-16
US5118698A (en) 1992-06-02
IE904282A1 (en) 1991-06-05
CY1970A (en) 1997-09-05
KR940000066B1 (ko) 1994-01-05
ATE102051T1 (de) 1994-03-15
SK595390A3 (en) 2000-04-10
KR910009286A (ko) 1991-06-28
RU2038080C1 (ru) 1995-06-27
EP0430149A3 (en) 1991-09-25
CN1035357C (zh) 1997-07-09
DK0430149T3 (da) 1994-03-28
PT96003B (pt) 1998-01-30
NO180475B (no) 1997-01-20
HK216896A (en) 1996-12-27
SK280599B6 (sk) 2000-04-10
MY104540A (en) 1994-04-30
CA2030911A1 (en) 1991-05-30
EP0430149B1 (en) 1994-03-02
NZ236255A (en) 1992-02-25
IE64672B1 (en) 1995-08-23
DE69007029T2 (de) 1994-06-09
JPH0660097B2 (ja) 1994-08-10
MX23518A (es) 1993-04-01
NO905106D0 (no) 1990-11-26

Similar Documents

Publication Publication Date Title
NL300034I2 (nl) Gesubstitueerde thiahzolidinedionderivaten.
AU6128590A (en) Novel compounds
AU6129890A (en) Novel compounds
SE7906472L (sv) Nya 3-(aminoetyl)-fenol-derivat och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
ATE109770T1 (de) Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten.
FI881816A0 (fi) Nya bicykliska foereningar, foerfarane foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI905814A0 (fi) Farmaceutiska produkter.
FI104071B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 2,5-dihydro-2,5-diokso-1H-bents£b|atsepiinijohdannaisten valmistamiseksi
DK451389D0 (da) 2-substituerede 4,5-diaryl-thioimidazoler samt farmaceutisk praeparat indeholdende saadanne forbindelser
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
FR2682952B1 (fr) Nouveaux n-(mercaptoacyl) amino-acides, leur preparation et les compositions pharmaceutiques qui les contiennent.
ATE117682T1 (de) Substituierte benzothiazolinone, ihre herstellung und sie enthaltende pharmazeutische zusammenstellungen.
SE8100122L (sv) Nya 2-aminometyl-6-halo-fenoler, framstellning derav och farmaceutiska kompositioner innehallande dessa
DE3784883D1 (de) Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: HEINRICH MACK NACHF.